Dr Christophe Willekens
- Specialty
- Hematologist, myeloma and leukemia expert
- Hospital
- Gustave Roussy (Villejuif)
- Latest articles
-
- Comparison of induction with arsenic trioxide or chemotherapy in a real-world cohort of patients with high-risk acute promyelocytic leukemia. (Jun 24, 2025)
- Reduced venetoclax exposure to 7 days vs standard exposure with hypomethylating agents in newly diagnosed AML patients. (Apr 17, 2025)
- Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm. (Feb 25, 2025)
- Circulating Proteins Associated with Anti-IL6 Receptor Therapeutic Resistance in the Sera of Patients with Severe COVID-19. (Nov 1, 2024)
- CXCL8 secreted by immature granulocytes inhibits WT hematopoiesis in chronic myelomonocytic leukemia. (Sep 17, 2024)